David F Burgstahler - Net Worth and Insider Trading

David F Burgstahler Net Worth

The estimated net worth of David F Burgstahler is at least $52 Million dollars as of 2024-11-05. David F Burgstahler is the Director of Lantheus Holdings Inc and owns about 300,332 shares of Lantheus Holdings Inc (LNTH) stock worth over $34 Million. David F Burgstahler is the Director, 10% Owner of AngioDynamics Inc and owns about 2,356,996 shares of AngioDynamics Inc (ANGO) stock worth over $16 Million. David F Burgstahler is also the Director, 10% Owner of Syneos Health Inc and owns about 39,713 shares of Syneos Health Inc (SYNH) stock worth over $2 Million. Besides these, David F Burgstahler also holds RVL Pharmaceuticals PLC (RVLPQ) . Details can be seen in David F Burgstahler's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David F Burgstahler has not made any transactions after 2022-08-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of David F Burgstahler

To

David F Burgstahler Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David F Burgstahler owns 8 companies in total, including Organogenesis Holdings Inc (ORGO) , RVL Pharmaceuticals PLC (RVLPQ) , and WideOpenWest Inc (WOW) among others .

Click here to see the complete history of David F Burgstahler’s form 4 insider trades.

Insider Ownership Summary of David F Burgstahler

Ticker Comapny Transaction Date Type of Owner
ORGO Organogenesis Holdings Inc 2018-08-17 director & 10 percent owner
RVLPQ RVL Pharmaceuticals PLC 2022-08-08 director & 10 percent owner
WOW WideOpenWest Inc 2017-05-24 director
LIMIT LIMIT 2017-09-07 director & 10 percent owner
LIMIT LIMIT 2016-09-19 director & 10 percent owner
LIMIT LIMIT 2017-04-12 director & 10 percent owner
LIMIT LIMIT 2022-12-01 director & 10 percent owner
LIMIT LIMIT 2022-12-01 director & 10 percent owner

David F Burgstahler Latest Holdings Summary

David F Burgstahler currently owns a total of 4 stocks. Among these stocks, David F Burgstahler owns 300,332 shares of Lantheus Holdings Inc (LNTH) as of September 7, 2017, with a value of $34 Million and a weighting of 65.31%. David F Burgstahler owns 2,356,996 shares of AngioDynamics Inc (ANGO) as of April 12, 2017, with a value of $16 Million and a weighting of 31.4%. David F Burgstahler also owns 39,713 shares of Syneos Health Inc (SYNH) as of September 19, 2016, with a value of $2 Million and a weighting of 3.28%. The other 1 stocks RVL Pharmaceuticals PLC (RVLPQ) have a combined weighting of 0% among all his current holdings.

Latest Holdings of David F Burgstahler

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LNTH Lantheus Holdings Inc 2017-09-07 300,332 113.03 33,945,024
ANGO AngioDynamics Inc 2017-04-12 2,356,996 6.93 16,322,197
SYNH Syneos Health Inc 2016-09-19 39,713 42.98 1,706,865
RVLPQ RVL Pharmaceuticals PLC 2022-08-08 1,032,995 0.00 0

Holding Weightings of David F Burgstahler


David F Burgstahler Form 4 Trading Tracker

According to the SEC Form 4 filings, David F Burgstahler has made a total of 0 transactions in Lantheus Holdings Inc (LNTH) over the past 5 years. The most-recent trade in Lantheus Holdings Inc is the sale of 102,958 shares on September 7, 2017, which brought David F Burgstahler around $2 Million.

According to the SEC Form 4 filings, David F Burgstahler has made a total of 0 transactions in AngioDynamics Inc (ANGO) over the past 5 years. The most-recent trade in AngioDynamics Inc is the sale of 2,350,000 shares on April 12, 2017, which brought David F Burgstahler around $38 Million.

According to the SEC Form 4 filings, David F Burgstahler has made a total of 0 transactions in Syneos Health Inc (SYNH) over the past 5 years. The most-recent trade in Syneos Health Inc is the acquisition of 1,000 shares on September 19, 2016, which cost David F Burgstahler around $43,190.

More details on David F Burgstahler's insider transactions can be found in the Insider Trading History of David F Burgstahler table.

Insider Trading History of David F Burgstahler

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David F Burgstahler Trading Performance

GuruFocus tracks the stock performance after each of David F Burgstahler's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David F Burgstahler is -2.89%. GuruFocus also compares David F Burgstahler's trading performance to market benchmark return within the same time period. The performance of stocks bought by David F Burgstahler within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David F Burgstahler's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David F Burgstahler

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 23.83 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 23.96 LIMIT LIMIT LIMIT LIMIT LIMIT

David F Burgstahler Ownership Network

Ownership Network List of David F Burgstahler

No Data

Ownership Network Relation of David F Burgstahler

Insider Network Chart

David F Burgstahler Owned Company Details

What does Organogenesis Holdings Inc do?

Who are the key executives at Organogenesis Holdings Inc?

David F Burgstahler is the director & 10 percent owner of Organogenesis Holdings Inc. Other key executives at Organogenesis Holdings Inc include 10 percent owner Albert Erani , 10 percent owner Michael W Katz , and director & President and CEO Gary S. Gillheeney .

Organogenesis Holdings Inc (ORGO) Insider Trades Summary

Over the past 18 months, David F Burgstahler made no insider transaction in Organogenesis Holdings Inc (ORGO). Other recent insider transactions involving Organogenesis Holdings Inc (ORGO) include a net sale of 431,786 shares made by Albert Erani ,

In summary, during the past 3 months, insiders sold 0 shares of Organogenesis Holdings Inc (ORGO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 431,786 shares of Organogenesis Holdings Inc (ORGO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 431,786 shares.

Organogenesis Holdings Inc (ORGO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Organogenesis Holdings Inc Insider Transactions

No Available Data

David F Burgstahler Mailing Address

Above is the net worth, insider trading, and ownership report for David F Burgstahler. You might contact David F Burgstahler via mailing address: C/o Warner Chilcott Holdings Co., Ltd., 100 Enterprise Drive, Rockaway Nj 07866.